As per MRFR analysis, the Bioprocess Containers Market Size was estimated at 2.93 (USD Billion) in 2024. The Bioprocess Containers Market Industry is expected to grow from 3.58 (USD Billion) in 2025 to 21.78 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 22.20% during the forecast period (2025 - 2034). The lower risk of cross-contamination and growing demand for biological products are the key market driver enhancing market growth 
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
During the forecast period, interest in biologics and biosimilars is anticipated to propel the global market. The market is also being expanded by the move toward single-use technologies that enable quicker production deadlines. Another significant factor driving the growth of the international bioprocess containers market is the rise in the privatization of laboratory services. The major drivers of the market's expansion are the increasing incidences of cancer and immunological disorders around the world, which call for the use of vaccines and biologics, as well as their choice for immunotherapy and chemotherapy, which increases the demand for bioprocess containers. Therefore, the increased cancer burden and investment in medicines development are anticipated to fuel growth in the market under study. When producing diverse high-performance systems, bioprocess containers are easily incorporated.
As a result of the factors above, the requirement for bioprocess containers is anticipated to develop over the projected period. Additionally, vaccines are among the most significant types of biologics utilized for managing a variety of medical illnesses, and businesses are substantially investing in creating vaccinations for many diseases, including uncommon ones, which is further predicted to spur market expansion. High levels of sterility are necessary for creating biologics, including therapeutic vaccines, gene and cell therapies, and biologics produced using single-use tools and materials. The sum of these variables is anticipated to accelerate the market for bioprocess containers. Additionally, because creating and producing biologics is so expensive, businesses operating in the industry are increasingly exploring alternatives to conventional biological manufacturing techniques that are less expensive. Higher product yields are also possible thanks to developing innovative materials, bag layouts, and assembly methods for bioprocess containers. The possibilities of single-use technology are increasing as a result.
News:
According to Thermo Fisher, its manufacturing facility in Lebanon, Tennessee, will bring materials closer to clients and is the main single-use bioproduction facility in its network. Thermo Fisher Scientific stated that the Greater Nashville plant will enable the company to meet rising demand for materials needed to produce vaccines and therapies for cancer and various other diseases. The $105 million expansion is part of a $650 million long-term investment the company stated last March. The Lebanon factory, located outside of Nashville, will produce fluid transfer assembly systems and customizable single-use bioprocess containers, both of which are in great demand by biopharmaceutical firms. This will guarantee a steady supply of essential components to produce vaccines and biopharmaceuticals.
Biologics currently account for nearly half of the oncology pharmacology market. Nearly 20 oncology biologic patents are set to expire by 2023. Biologic patent expiry is expected to delay the launch of biosimilars. The application of disposable systems in biosimilar development is expected to increase the demand for bioprocess containers. Thus, drving the market CAGR.
Biologics development, such as gene and cell therapies and therapeutic vaccines, requires high sterility, and biologics are increasingly manufactured with single-use consumables and equipment. All these factors are cumulatively expected to boost the growth of the Bioprocess Containers market. Furthermore, the cost of developing and manufacturing biologics is so high that companies operating in the market are increasingly looking for less expensive technologies than traditional biological manufacturing methods. Several biopharmaceutical manufacturers are incorporating disposable bioprocessing technologies into their development to produce cost-effective products. Thus it led to the expansion of bioprocess containers market revenue.
Figure 1: Bioprocess systems markets from 2013-2023 (in billion USD)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Factors such as eliminating the need for sterilization, increasing operational efficiency, and reducing manufacturing time for many pharmaceuticals rapidly increase the demand for single-use technologies, especially in biomanufacturing. At the same time, a reduction in manufacturing costs is expected to drive market growth. In addition, the sustainability and affordability of single-use bioprocess containers and reduced cross-contamination risk contribute to the market growth. However, the high cost of equipment may act as a hindrance to market growth. Moreover, introducing new drugs into the market is a significant growth opportunity.
Based on the type, the Bioprocess Containers market segmentation includes 2D containers, 3D containers, and accessories. The 2D bioprocess containers segment held the majority share in 2022 for the Bioprocess Containers market revenue owing to its ability to accelerate existing biopharmaceutical manufacturing processes and the fact that it aids in media preparation, liquid management, and product storage.
2D bioprocess containers are widely used for cell harvesting, bulk drug and precursor delivery. Therefore, investments in developing and expanding biologics production are expected to increase the demand for 2D bioprocess containers, which is expected to drive the segment's growth. Several companies offer advanced 2D bioprocessing containers, including Thermo Fisher, CellBios, and Cole-Palmer.
February 2022:Â ALLpaQ Packaging Group has launched a new range of ALLpaQ 500 PLUS bioprocess containers. The company announced investments in bioprocess containers to lead the market and meet customer demands.
The Bioprocess Containers market data has been bifurcated by application into upstream, downstream, and production processes. The upstream process segment dominated the market in 2022 due to the widespread use of bioprocess containers, especially during fermentation, mixing, and media processing. This contributes to the growth of the Bioprocess Containers market. Additionally, modern cell culture systems produce very high titers while reducing lab-to-production bioreactor time.
November 2021: Bionova opened a USD 25.0 million single-use plant in Fremont, California. The plant is equipped with a 1,000 L Cytiva XDR upstream train.
The Bioprocess Containers market includes pharmaceutical and biotech companies based on end users. Pharmaceutical companies extensively use modern technology to combine single-use components into single-use unit operations, resulting in the potential integration of unit operations into single-use processes. This single-use within an aseptic process offers advantages for producing high-quality products without the risk of cross-contamination. Hence, rising End User options for Bio-process Containers positively impact market growth.
August 2022:Â Innovent Biologics of China and Paris-based Sanofi invested USD 2.42 billion in the biopharma group to jointly develop two cancer drugs in China.
Figure 2: Bioprocess Containers market by End-User, 2022 & 2030 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
News:
The innovative company maintains its vendor-agnostic strategy while leveraging its expertise to offer dependable process options in managing biopharmaceutical fluids. IRIS single-use bags are introduced to the biopharmaceutical sector by Single Use Support GmbH. IRIS single-use bags result from the company's considerable knowledge of how various single-use containers and assemblies behave throughout crucial steps like protection, filling and draining, freezing and thawing, preservation, and shipping of medicinal substances. All Single Use Support sterile consumables are branded with the initials IRIS, representing the company's core values of innovation, robustness, individuality, and single-use.
By region, the study offers market insights into Asia-Pacific, Europe, North America, and Rest of the World. The North America Bioprocess Containers market accounted for USD 0.87 billion in 2022 and is anticipated to exhibit a substantial CAGR growth during the study period, attributed to the high demand for biopharmaceuticals due to an aging population and advanced healthcare infrastructure in the United States. Also, the presence of major players focused on research activities, and huge investments in healthcare by US-based manufacturers contribute to its remarkable global market growth.
Further, the key countries studied in the market report are: The U.S, Canada, UK, Italy, Spain, Germany, France, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3:Â BIOPROCESS CONTAINERS MARKETÂ SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Bioprocess Containers market accounts for the second-largest market share due to the increase in life science R&D companies and biologics manufacturing sectors. The extensive presence of biotech companies fuels the market's growth. Major European players are more focused development of innovative bioprocess containers to enhance operational efficiency, which also plays an important role in market growth. Additionally, increasing demand for biological products and biopharmaceuticals is boosting the growth of the bioprocess container market in the region. Moreover, UK Bioprocess Containers market held the largest market share, and the Germany Bioprocess Containers market was the fastest growing market in the Asia-Pacific region
The Asia-Pacific Life, Science Analytics Market, is anticipated to increase at the fastest CAGR from 2023 to 2030 due to the Increasing R&D activities, better pharmaceutical infrastructure, and relatively cheap labor costs driving the market growth. For example, in May 2017, Merck opened its first joint bioprocess scale-up lab with his Stelis Biopharma in Bangalore, India, providing an end-to-end solution for preclinical, clinical and commercial supply. Moreover, China Bioprocess Containers market held the largest market share, and the India Bioprocess Containers market was the fastest growing market in the Asia-Pacific region
Key market players are spending a large portion of money on research & development to increase their product lines, which will help the Bioprocess Containers market grow even more. Market players are also taking several strategic initiatives to increase their worldwide footprint, with key market developments such as mergers and acquisitions, contractual agreements, increased investments, new product launches, and collaboration with other organizations. Competitors in the Bioprocess Containers industry must expand their business footprint to survive in an increasingly competitive and rising market environment.
One of the manufacturers primary business strategies in the global Bioprocess Containers industry is to help clients and increase the market sector by increasing investment in R&D to enhance solutions and services. In recent years, the Bioprocess Containers industry has provided innovative solutions and reduced disruptions in the supply chain. The Bioprocess Containers markets major players such as Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), Meissner (US) and others are functioning on expanding the market demand by financing in research and development actions.
Thermo Fisher Scientific Inc. helps customers make the world healthier, cleaner and safer. It provides life science research, solving complex analytical challenges, increasing laboratory productivity, improving patient health through diagnostics, or developing and manufacturing life-changing therapeutics. It also offers an unrivaled combination of innovative technology, shopping convenience and pharmaceutical services through industry-leading brands such as Applied Biosystems, Thermo Scientific, Invitrogen, Unity Lab Services, Fisher Scientific, Patheon and PPD. For instance, In December 2020, Thermo Fisher introduced a 500 L capacity single-use bioreactor. Biopharmaceutical companies increasingly integrate single-use technology into perfusion and cGMP manufacturing processes.
Merck is a leading science and technology company. It is active in healthcare, life sciences and performance materials. Delivering gene-editing technology and discovering unique ways to treat the most challenging diseases enable intelligence in devices. For instance, in April 2020, Merck introduced the next component of the BioContinuum platform, the Bio4C software suite, creating a unique ecosystem that combines process control, analysis and plant-level automation. This innovative software suite allows users to see the entire manufacturing process.
April 2022:Â Thermo Fisher Scientific opened a single-use technology manufacturing site in Ogden, Utah. This creates additional capacity to produce the high-quality technology and materials needed for developing new vaccines and breakthrough therapies, thereby indicating the increased production of bioprocess containers.
July 2021:Â Cytiva and Pall Corporation invested more than 300.0 million in single-use technologies, including bioreactor bags for growing cells used to make personalized medicines and syringe filters for scientific research.
North America
Europe
Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Size 2024 | Â Â 2.93 (USD Billion) |
| Market Size 2025 | Â Â 3.58 (USD Billion) |
| Market Size 2034 | Â 21.78 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | Â 22.20 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Report Coverage | Market Competitive Landscape, Growth Factors, Revenue Forecast, and Trends |
| Segments Covered | Type, Application, End Users, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, UK, Italy, Germany, France, Spain, India, China, Japan, Australia, South Korea, and Brazil |
| Key Companies Profiled | Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), and Meissner (US) |
| Key Market Opportunities | Increasing the use of cost-effective products |
| Key Market Dynamics | High development and manufacturing costs of biologics coupled with expiring patents should increase demand for single-use bioprocessing technologies. |
Frequently Asked Questions (FAQ) :
The market size of global Bioprocess Containers was valued at USD 1.90 Billion in 2022.
The global market is projected to grow at a CAGR of 22.20% during the forecast period, 2025-2034.
North America had the leading share of the global market
The key players in the market are Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), Meissner (US), and others.
The foam 2D Bioprocess Containers category dominated the market in 2021.
The pharmaceutical company's application had the largest global market share.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
